BLFA’s Pathology Improvement Program (PIP), along with our corporate partner Beckman Coulter and our African collaborators in both Uganda and Kenya, successfully implemented state-of-the-art flow cytometry diagnostic equipment at Moi Teaching and Referral Hospital (MTRH) in Kenya and Uganda National Health Laboratory Services (UNHLS). This allows them to provide more rapid and accurate diagnosis for childhood cancer patients. Thrilled about this new equipment, MTRH Pediatrician Dr. Gilbert Olbara commented, “If we address the initial delays in our patients, then we’ll be able to improve the outcome of overall survival.” Every day saved in diagnosis and every treatment completed has the potential to save a child’s life.
Practitioners at the Moi Teaching and Referral Hospital measured the impacts of this new technology. They found that using this diagnostic equipment decreased time to diagnosis from 10 to 7 days. The earlier and more accurate diagnosis led to a significant decline in treatment abandonment from 35% to less than 5%. Most notably, Burkitts Lymphoma patients diagnosed after implementing this equipment had a survival rate of about 75% at 100 days post-diagnosis, compared to the historical 100-day survival rate of around 55% - a 20% increase.
Partner: Beckman Coulter, Moi Teaching and Referral Hospital
Source: Dr. Gilbert Olbara, AORTIC 2021 Workshop, 2021 Pediatric Blood Cancer Study